Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.435\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. COc1ccc(/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1
b. CCOC(=O)c1c(NC(N)=O)sc(C)c1C
Answer: a. COc1ccc(/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1
COc1ccc(/C=C2/SC(=S)N(CCC(=O)O)C2=O)cc1
3-[(5E)-5-[(4-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid